CREB1 and Huntington disease: Phosphodiesterase inhibition restored the protein levels of CREB and BDNF in the brain of the R6/2 transgenic mouse model, thereby reducing the degeneration of the striatum and cortex.628 Therefore, the primary focus of HD-related clinical trials later turned to the efficacy and safety of phosphodiesterase inhibitors.